Skip to main content

Olaparib (O) in patients (pts) with prostate cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.

Publication ,  Conference
Pisick, EP; Garrett-Mayer, E; Halabi, S; Mangat, PK; Yang, ES-H; Dib, EG; Burgess, EF; Zakem, MH; Rohatgi, N; Bilen, MA; Warren, SL ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

15

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pisick, E. P., Garrett-Mayer, E., Halabi, S., Mangat, P. K., Yang, E.-H., Dib, E. G., … Schilsky, R. L. (2020). Olaparib (O) in patients (pts) with prostate cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Pisick, Evan P., Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Eddy Shih-Hsin Yang, Elie G. Dib, Earle Frederick Burgess, et al. “Olaparib (O) in patients (pts) with prostate cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Pisick EP, Garrett-Mayer E, Halabi S, Mangat PK, Yang ES-H, Dib EG, et al. Olaparib (O) in patients (pts) with prostate cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Pisick EP, Garrett-Mayer E, Halabi S, Mangat PK, Yang ES-H, Dib EG, Burgess EF, Zakem MH, Rohatgi N, Bilen MA, Warren SL, Anderson ST, Rygiel AL, Schilsky RL. Olaparib (O) in patients (pts) with prostate cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. JOURNAL OF CLINICAL ONCOLOGY. 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

15

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences